BGPT: Visualize Data: Recreate brain enrichment and temporal trajectory summaries from paper numbers

Explore by Goal

Quick Analysis Plan Copied

The requested brain enrichment and temporal trajectory summaries cannot be recreated: none of the supplied evidence records contain brain-specific enrichment data or temporal trajectory data. The records cover EGFR trafficking, NSCLC drug response, and FUT8-mediated antiviral signaling . Please upload the brain-enrichment paper or dataset.

Long Analysis Plan

Requested data are not present in the supplied records

The evidence records provided contain no brain tissue enrichment data (e.g., no tissue-specific gene-expression enrichments, no GTEx-style brain scores) and no temporal trajectory data (no time-series measurements). The four claim-level records cover EGFR trafficking/LDOC1 in NSCLC, EGFR copy-number screening, FUT8 core fucosylation during viral infection, and EGFR-TKI sensitivity profiling. To recreate brain enrichment or temporal trajectory summaries, the relevant source paper numbers must be supplied.

The only quantitative values available are NSCLC-focused: LDOC1 high/low distributions (55/45 EGFR-WT; 58/42 EGFR-mutant), cytoplasmic EGFR percentages by LDOC1 status (9.1–59.5%), and HCC827 gefitinib IC50 shifting from 1.8 to 2.3 µM with LDOC1 depletion . These cannot be re-expressed as brain enrichment or trajectory summaries without fabrication.

Feedback:

Updated: October 24, 2026

Top Data Sources Export MCP

1. LDOC1 interacts with clathrin adaptors AP1M1 and AP2M1 to regulate EGFR internalization and recycling, modulating EGFR signaling and gefitinib response in EGFR-mutant NSCLC, with LDOC1 loss promoting RTK activation and gefitinib resistance while associating with poorer patient outcomes. [2024]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

2. This study demonstrates that pSTAT3 transactivates EGFR to maintain EGFR protein homeostasis and contributes to resistance against EGFR tyrosine kinase inhibitors in non-small cell lung cancer cells. [2024]

8QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

3. This study investigates the relationship between EGFR gene copy number alterations and EGFR mutation status in lung adenocarcinoma, concluding that EGFR gene copy number as detected by SISH is not a reliable screening tool for selecting patients for EGFR mutation testing. [2014]

7QualityResults Limitations Context Blindspots Methods Sample Data

↗ Paper Review ↗ Full Paper

4. A comprehensive review of EGFR pathway alterations in NSCLC, detailing activating EGFR mutations, copy-number changes, downstream signaling, predictive biomarkers for EGFR-targeted therapies, and mechanisms of resistance, with emphasis on the need for integrated molecular stratification for personalized treatment. [2011]

8QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

5. The study shows that hepatitis C virus (and other enveloped viruses) upregulates host FUT8 to increase EGFR core fucosylation, activating EGFR-JAK1-STAT3 signaling that recruits Trim40 to promote RIG-I degradation and suppresses type I interferon responses, with FUT8 inhibition or hepatic Fut8 silencing reducing RNA viral replication in vitro and in vivo, revealing a viral immune evasion mechanism and potential antiviral target. [2024]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

Key Insight

Nothing supplied pertains to brain biology; proceeding without source numbers would require fabricating data, so the correct scientific move is refusal to graph plus a precise request for the missing inputs.

Keep Exploring

Which quantitative tables from the brain enrichment paper are needed to reproduce its enrichment figures exactly?

What statistical thresholds (FDR, fold-enrichment cutoffs) govern the paper's temporal trajectory summaries?

Analysis Wizard

Awaiting the brain-enrichment and temporal trajectory source numbers before coding any summary visualization.

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I may over-reject ambiguous queries; here the supplied records clearly lack brain or trajectory data, so rejection is evidence-based.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

Bioinformatics Claims With Provenance

Trace tool comparisons and pipeline results back to exact experiments and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Analysis Plan Copied

Long Analysis Plan

Requested data are not present in the supplied records

Top Data Sources Export MCP

1. LDOC1 interacts with clathrin adaptors AP1M1 and AP2M1 to regulate EGFR internalization and recycling, modulating EGFR signaling and gefitinib response in EGFR-mutant NSCLC, with LDOC1 loss promoting RTK activation and gefitinib resistance while associating with poorer patient outcomes. [2024]

2. This study demonstrates that pSTAT3 transactivates EGFR to maintain EGFR protein homeostasis and contributes to resistance against EGFR tyrosine kinase inhibitors in non-small cell lung cancer cells. [2024]

3. This study investigates the relationship between EGFR gene copy number alterations and EGFR mutation status in lung adenocarcinoma, concluding that EGFR gene copy number as detected by SISH is not a reliable screening tool for selecting patients for EGFR mutation testing. [2014]

10. Src-mediated phosphorylation of CIN85 after EGF stimulation promotes CIN85 binding to the E3 ligase c-Cbl, enhancing EGFR ubiquitination and sorting into multivesicular bodies for degradation, whereas preventing CIN85 phosphorylation traps EGFR in early endosomes and delays degradation. [2012]

12. This narrative review argues that EGFR-mutated NSCLC has an immunosuppressive tumor microenvironment, low TMB, altered PD-L1/CD8/Treg/TAM features, and immunotherapy resistance, supporting combined TKI/immunotherapy and inflammation-targeting strategies. [2022]

Ask a Follow-Up

Key Insight

Nothing supplied pertains to brain biology; proceeding without source numbers would require fabricating data, so the correct scientific move is refusal to graph plus a precise request for the missing inputs.

Keep Exploring

Which quantitative tables from the brain enrichment paper are needed to reproduce its enrichment figures exactly?

What statistical thresholds (FDR, fold-enrichment cutoffs) govern the paper's temporal trajectory summaries?

Analysis Wizard

Awaiting the brain-enrichment and temporal trajectory source numbers before coding any summary visualization.

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I may over-reject ambiguous queries; here the supplied records clearly lack brain or trajectory data, so rejection is evidence-based.

Stay current without chasing every paper.

My BGPT

Trending

Bioinformatics Claims With Provenance

Trace tool comparisons and pipeline results back to exact experiments and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Analysis Plan Copied

Long Analysis Plan

Requested data are not present in the supplied records

Top Data Sources ExportMCP

1. LDOC1 interacts with clathrin adaptors AP1M1 and AP2M1 to regulate EGFR internalization and recycling, modulating EGFR signaling and gefitinib response in EGFR-mutant NSCLC, with LDOC1 loss promoting RTK activation and gefitinib resistance while associating with poorer patient outcomes. [2024]

2. This study demonstrates that pSTAT3 transactivates EGFR to maintain EGFR protein homeostasis and contributes to resistance against EGFR tyrosine kinase inhibitors in non-small cell lung cancer cells. [2024]

3. This study investigates the relationship between EGFR gene copy number alterations and EGFR mutation status in lung adenocarcinoma, concluding that EGFR gene copy number as detected by SISH is not a reliable screening tool for selecting patients for EGFR mutation testing. [2014]

10. Src-mediated phosphorylation of CIN85 after EGF stimulation promotes CIN85 binding to the E3 ligase c-Cbl, enhancing EGFR ubiquitination and sorting into multivesicular bodies for degradation, whereas preventing CIN85 phosphorylation traps EGFR in early endosomes and delays degradation. [2012]

12. This narrative review argues that EGFR-mutated NSCLC has an immunosuppressive tumor microenvironment, low TMB, altered PD-L1/CD8/Treg/TAM features, and immunotherapy resistance, supporting combined TKI/immunotherapy and inflammation-targeting strategies. [2022]

Ask a Follow-Up

Key Insight

Nothing supplied pertains to brain biology; proceeding without source numbers would require fabricating data, so the correct scientific move is refusal to graph plus a precise request for the missing inputs.

Keep Exploring

Which quantitative tables from the brain enrichment paper are needed to reproduce its enrichment figures exactly?

What statistical thresholds (FDR, fold-enrichment cutoffs) govern the paper's temporal trajectory summaries?

Analysis Wizard

Awaiting the brain-enrichment and temporal trajectory source numbers before coding any summary visualization.

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I may over-reject ambiguous queries; here the supplied records clearly lack brain or trajectory data, so rejection is evidence-based.

Stay current without chasing every paper.

My BGPT

Trending

Top Data Sources Export MCP